Stay updated on Faricimab in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label advances from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T18:51:54.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:31:22.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    403 Forbidden page now replaces the study record, turning the page into an access-denied screen. The study details, documents, and related content are no longer visible to users.
    Difference
    18%
    Check dated 2026-09-22T21:54:18.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, reflecting a new update to the study record's documentation. This change does not alter the study details or data accessible on the page.
    Difference
    0.0%
    Check dated 2026-09-15T21:44:53.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated to v3.6.6, indicating a small, behind-the-scenes update to the page template or metadata.
    Difference
    0.0%
    Check dated 2026-09-01T18:08:11.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added a new entry '2018 ( U.S. NIH Grant/Contract )' to the study's identifiers section, recording NIH funding associated with the trial. This update updates the funding disclosures reflected in the study's metadata.
    Difference
    0.0%
    Check dated 2026-08-25T20:30:27.000Z thumbnail image

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.